MMP9 and allergic disease: A customized AbMA test was fabricated for tear MMP-9 quantification in human samples, managing to detect the biomarker in pathologies that involve inflammation of the ocular surface, such as cataracts, glaucoma, meibomian gland dysfunction, allergy, or dry eye.